These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33179900)

  • 1. Nonalcoholic Fatty Liver Disease.
    Am Fam Physician; 2020 Nov; 102(10):Online. PubMed ID: 33179900
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease and Obesity Treatment.
    Brunner KT; Henneberg CJ; Wilechansky RM; Long MT
    Curr Obes Rep; 2019 Sep; 8(3):220-228. PubMed ID: 30945129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease.
    Hannah WN; Harrison SA
    Clin Liver Dis; 2016 May; 20(2):339-50. PubMed ID: 27063273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis.
    Ratziu V; Ghabril M; Romero-Gomez M; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):28-38. PubMed ID: 30300289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Hung CK; Bodenheimer HC
    Clin Liver Dis; 2018 Feb; 22(1):175-187. PubMed ID: 29128055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Nonalcoholic Fatty Liver Disease.
    Paul S; Davis AM
    JAMA; 2018 Dec; 320(23):2474-2475. PubMed ID: 30476962
    [No Abstract]   [Full Text] [Related]  

  • 7. Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review.
    Cui H; Zhang X
    J Pediatr Endocrinol Metab; 2020 May; 33(5):579-584. PubMed ID: 32187014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Markers of Improvement of Liver Steatosis Achieved by Weight Reduction in Patients with Nonalcoholic Fatty Liver Disease.
    Copaci I; Lupescu I; Caceaune E; Chiriac G; Ismail G
    Rom J Intern Med; 2015; 53(1):54-62. PubMed ID: 26076562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease: when to intervene and with what.
    Than NN; Newsome PN
    Clin Med (Lond); 2015 Apr; 15(2):186-90. PubMed ID: 25824073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current solutions for obesity-related liver disorders: non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Raziel A; Sakran N; Szold A; Goitein D
    Isr Med Assoc J; 2015 Apr; 17(4):234-8. PubMed ID: 26040050
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research.
    Gottlieb A; Mosthael W; Sowa JP; Canbay A
    Digestion; 2019; 100(2):79-85. PubMed ID: 30537758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of NAFLD and Its Management.
    Mundi MS; Velapati S; Patel J; Kellogg TA; Abu Dayyeh BK; Hurt RT
    Nutr Clin Pract; 2020 Feb; 35(1):72-84. PubMed ID: 31840865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
    Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
    Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.
    Diehl AM; Day C
    N Engl J Med; 2017 Nov; 377(21):2063-2072. PubMed ID: 29166236
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonalcoholic Steatohepatitis: A Review.
    Sheka AC; Adeyi O; Thompson J; Hameed B; Crawford PA; Ikramuddin S
    JAMA; 2020 Mar; 323(12):1175-1183. PubMed ID: 32207804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment.
    Kim KS; Lee BW; Kim YJ; Lee DH; Cha BS; Park CY
    Diabetes Metab J; 2019 Apr; 43(2):127-143. PubMed ID: 30993937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
    Roeb E; Geier A
    Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.
    Chitturi S; Wong VW; Chan WK; Wong GL; Wong SK; Sollano J; Ni YH; Liu CJ; Lin YC; Lesmana LA; Kim SU; Hashimoto E; Hamaguchi M; Goh KL; Fan J; Duseja A; Dan YY; Chawla Y; Farrell G; Chan HL
    J Gastroenterol Hepatol; 2018 Jan; 33(1):86-98. PubMed ID: 28692197
    [No Abstract]   [Full Text] [Related]  

  • 19. How to Approach a Patient With Nonalcoholic Fatty Liver Disease.
    Tilg H
    Gastroenterology; 2017 Aug; 153(2):345-349. PubMed ID: 28647352
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage.
    Giannini EG; Coppo C; Romana C; Camerini GB; De Cian F; Scopinaro N; Papadia FS
    Dig Dis Sci; 2018 Jul; 63(7):1946-1951. PubMed ID: 29629490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.